COVID-19 task force speaks on Johnson & Johnson vaccine pause

Members of the White House COVID-19 task force discussed the Johnson & Johnson vaccine pause and how that might affect vaccine hesitancy.
4:13 | 04/14/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:



Skip to this video now

Now Playing:


Related Extras
Related Videos
Video Transcript
Transcript for COVID-19 task force speaks on Johnson & Johnson vaccine pause
CDC and FDA weren't boarded six cases are rare types of life call cerebral being tests I asked about. Heard in combination. With low level I or a condition known addict. Few individuals and these are also had an hour Donald more than gained on their gastrointestinal. Cases were reported to the vaccine accurate about or that I'm known as errors. Just the fifth and the CDC and FDA all manner to service an early warning system time monitor it to be seen. All six individuals. Or women between the ages 1848. And their symptoms president didn't sixth to thirteen days. Anywhere acts and what are ya. I wanna take a step back and explain how these events it into what we know about John. Our latest data shows that we had administered more than seven million dollars adopt the vaccine and have you observed on sixth and the arts. Right now we believe these events should be extremely. Rare while we are also not yet certain we have heard about all off or she is. This syndrome may not he easily recognized as one associate at the scene. CDC and FDA are working rapidly to about G-8. And understand why aren't there is a causal relationship in what our vaccine administration. The decision to hot in this age. Vaccine was made specifically for three reasons. First we want to alert a health care providers should be on the lookout for these rare. Post vaccination and to make sure that they are treating patients. Really it is imperative for our workers know that treatment. Is different and our current standard error. While he would typically treat blood clots with the medication. Brent. Print and its derivatives should and it wouldn't be appointed. In the treatment at these are my own and asked each other content on. Second. There may be additional. Reports. We want people who need to vaccine and their health care provider should be aware. Report and ENFDA. Through the barest. And third. Possible allow our independent committee assigned. Are reviewed the safety information on his acts and these events to determine their. I know the information we presented me be very concerned Americans especially those who already ST on our. Or people who receive the vaccine more than among the risk but what are in exceptional. People who receive the vaccine mean who recently meaning more than a week. They should be aware of their symptoms and immediately seek medical assistance and any symptoms aren't also I want to reiterate. Even and these are bad are extremely radar. I'd like to do is just spend bitterness so just kidding weren't aspect of this discussion. That we have been questioned on they only intensively. Over the last 24 hours and that is. The issue of whether or not. This action on the part of the CDC and EXE eight. Will actually be the issue of vaccine hesitancy. Even in war. Typical problem. As people see what's going on here. And then they then it essentially extrapolate that to the issue of tested and see not only this vaccine. But for all the vaccines that are available. The fact that Ali. EE UA. We have continued. To follow very carefully any possibility. Of adverse events I believe. Is the other side of the coin. Of hesitancy. It should reinforce. In those individuals. How we take safety. So seriously.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"4:13","description":"Members of the White House COVID-19 task force discussed the Johnson & Johnson vaccine pause and how that might affect vaccine hesitancy.","mediaType":"default","section":"ABCNews/Health","id":"77070060","title":"COVID-19 task force speaks on Johnson & Johnson vaccine pause","url":"/Health/video/covid-19-task-force-speaks-johnson-johnson-vaccine-77070060"}